Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.51 |
| ▸ | GNPAT | O15228 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 7/20 | 0.47 |
| ▸ | NPY1R | P25929 | 5/20 | 0.47 |
| ▸ | NPY2R | P49146 | 3/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.47 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504191 | 0.91 | NPY4R (0.53) | KISS1RFOLH1GNPATCTSLCTSK | |
| 4-Nitroaniline SCHEMBL27576311 | 0.90 | BACE1 (0.47) | KISS1RFOLH1GNPATSMN1; SMN2CTSK | |
| SCHEMBL30302999 | 0.89 | NPY4R (0.51) | GNPATSMN1; SMN2CTSKNPY4RNPY1R | |
| SCHEMBL30798743 | 0.89 | NPY4R (0.60) | GNPATSMN1; SMN2NPY4RNPY1RNPY2R | |
| SCHEMBL29732500 | 0.89 | NPY4R (0.56) | KISS1RGNPATSMN1; SMN2CTSKNPY4R | |
| SCHEMBL20250612 | 0.89 | SMN1; SMN2 (0.60) | KISS1RFOLH1GNPATSMN1; SMN2CTSK | |
| SCHEMBL5673367 | 0.89 | KISS1R (0.46) | KISS1RFOLH1SMN1; SMN2CTSLCTSK | |
| SCHEMBL11203835 | 0.88 | CTSL (0.48) | KISS1RCTSLCTSKCTSSNPY4R | |
| SCHEMBL14050130 | 0.88 | KISS1R (0.56) | KISS1RFOLH1CTSLCTSKCTSS | |
| SCHEMBL11302814 | 0.87 | NPY4R (0.50) | KISS1RGNPATSMN1; SMN2NPY4RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132678-A1 | QUALITATIVE TEST FOR DIRECT ORAL ANTICOAGULANTS (DOACS) | F. HOFFMANN-LA ROCHE AG (CH) | 2025-06-26 | — | — | WO | claimed |
| EP-3955003-B1 | SENSORS FOR ASSAYING COAGULATION IN FLUID SAMPLES | ABBOTT POINT OF CARE INC (US) | 2023-06-21 | — | — | EP | claimed |
| EP-3198281-B1 | ELLAGIC ACID FORMULATIONS FOR USE IN COAGULATION ASSAYS | ABBOTT POINT OF CARE INC (US) | 2023-01-25 | — | — | EP | claimed |
| EP-3955003-A1 | SENSORS FOR ASSAYING COAGULATION IN FLUID SAMPLES | Abbott Point Of Care Inc (US) | 2022-02-16 | — | — | EP | claimed |
| CN-109893647-A | Elastin laminin zymoprotein of recombination and its preparation method and application | 普罗特昂治疗公司 | 2019-06-18 | — | — | CN | claimed |
| WO-2025132678-A1 | QUALITATIVE TEST FOR DIRECT ORAL ANTICOAGULANTS (DOACS) | F. HOFFMANN-LA ROCHE AG (CH) | 2025-06-26 | — | — | WO | disclosed |
| EP-4473115-A1 | MIRROR-IMAGE SELECTION OF L-NUCLEIC ACID APTAMERS | Tsinghua University (CN) | 2024-12-11 | — | — | EP | disclosed |
| CN-112638532-B | Cartridge device with bypass channel for reducing fluid sample drift | 雅培医护站股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| WO-2023148646-A1 | MIRROR-IMAGE SELECTION OF L-NUCLEIC ACID APTAMERS | TSINGHUA UNIVERSITY (CN) | 2023-08-10 | — | — | WO | disclosed |
| EP-3955003-B1 | SENSORS FOR ASSAYING COAGULATION IN FLUID SAMPLES | ABBOTT POINT OF CARE INC (US) | 2023-06-21 | — | — | EP | disclosed |
| EP-3198281-B1 | ELLAGIC ACID FORMULATIONS FOR USE IN COAGULATION ASSAYS | ABBOTT POINT OF CARE INC (US) | 2023-01-25 | — | — | EP | disclosed |
| EP-4043879-A1 | SINGLE CHANNEL CARTRIDGE DEVICE FOR COAGULATION ASSAYS IN FLUID SAMPLES | Abbott Point Of Care Inc (US) | 2022-08-17 | — | — | EP | disclosed |
| WO-1999026926-A1 | HETEROARYL AMINOGUANIDINES AND ALKOXYGUANIDINES AND THEIR USE AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| EP-0821689-A1 | TUMOR PROTEASE ACTIVATED PRODRUGS OF PHOSPHORAMIDE MUSTARD ANALOGS | Drug Innovation & Design, Inc. (US) | 1998-02-04 | — | — | EP | disclosed |
| US-5659061-A | Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities | DRUG INNOVATION & DESIGN, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| WO-1996033198-A1 | TUMOR PROTEASE ACTIVATED PRODRUGS OF PHOSPHORAMIDE MUSTARD ANALOGS | DRUG INNOVATION & DESIGN, INC. (US) | 1996-10-24 | — | — | WO | disclosed |
| US-4430263-A | TRYPSIN INHIBITOR CONJUGATE WITH HAPTEN OR THYROXINE | ABBOTT LABORATORIES (US) | 1984-02-07 | — | — | US | disclosed |
| EP-0038357-A4 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS. | UNIV ILLINOIS (US) | 1982-03-22 | — | — | EP | disclosed |
| EP-0038357-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | University of Illinois Foundation (US) | 1981-10-28 | — | — | EP | disclosed |
| WO-1981001145-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | UNIV ILLINOIS (US) | 1981-04-30 | — | — | WO | disclosed |